Journal ArticleSchizophrenia bulletin · August 2025
Background and hypothesisTraditional assessments of schizophrenia's negative symptoms rely on subjective and time-consuming psychiatric interviews. To provide more objective and efficient evaluations, this study examines the efficacy of an automat ...
Full textCite
Chapter · January 1, 2025
Recent advancements in ultra-high-resolution unpaired image-to-image translation have aimed to mitigate the constraints imposed by limited GPU memory through patch-wise inference. Nonetheless, existing methods often compromise between the reduction of noti ...
Full textOpen AccessCite
Journal ArticleIEEE journal of biomedical and health informatics · February 2024
We present PathoOpenGait, a cloud-based platform for comprehensive gait analysis. Gait assessment is crucial in neurodegenerative diseases such as Parkinson's and multiple system atrophy, yet current techniques are neither affordable nor efficient. PathoOp ...
Full textCite
Journal ArticleNPJ digital medicine · February 2024
The Motor Disorder Society's Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is designed to assess bradykinesia, the cardinal symptoms of Parkinson's disease (PD). However, it cannot capture the all-day variability of bradykinesia outside the clinical ...
Full textCite
Chapter · January 1, 2022
While hematoxylin and eosin (H &E) is a standard staining procedure, immunohistochemistry (IHC) staining further serves as a diagnostic and prognostic method. However, acquiring special staining results requires substantial costs. Hence, we proposed a stra ...
Full textOpen AccessCite
Journal ArticleBioinformatics (Oxford, England) · May 2021
SummaryDrug discovery targeting G protein-coupled receptors (GPCRs), the largest known class of therapeutic targets, is challenging. To facilitate the rapid discovery and development of GPCR drugs, we built a system, PanGPCR, to predict multiple p ...
Full textCite